Syphilis and HIV: Old and new foes aligned against us

Current Infectious Disease Reports

Volumn 11, Issue 2, 2009, Pages 157-162

  Eaton, Molly ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; EPIDEMIC; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LOW DRUG DOSE; MORTALITY; NEUROSYPHILIS; NONHUMAN; PENICILLIN ALLERGY; RELAPSE; REVIEW; SAFE SEX; SEROLOGY; SEXUAL TRANSMISSION; SYPHILIS; TREPONEMA PALLIDUM;

EID: 62549147098     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0023-5     Document Type: Review

References (49)

1. Centers for Disease Control and Prevention: STD Surveillance 2006, National Profile. Available at http://www.cdc.gov/std/stats/ syphilis.htm. Accessed August 2008.
2. Centers for Disease Control and Prevention: Primary and secondary syphilis-United States, 2000-2001. MMWR Morb Mortal Wkly Rep 2002, 51: 971-973.
3. Heffelfinger JD, Swint EB, Berman SM, Weinstock HS: Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health 2007, 97: 1076-1083.
4. Centers for Disease Control and Prevention: Transmission of primary and secondary syphilis by oral sex-Chicago, Illinois, 1998-2002. MMWR Morb Mortal Wkly Rep 2004, 53: 966-968.
5. Simms I, Fenton KA, Ashton M, et al.: The re-emergence of syphilis in the United Kingdom: The new epidemic phases. Sex Transm Dis 2005, 32: 220-226.
6. Couturier E, Michel A, Janier M, et al.: Syphilis surveillance in France, 2000-2003. Euro Surveill 2004, 9: 8-10.
7. Jin F, Prestage GP, Kippax SC, et al.: Australian-Thai HIV Vaccine Consortium: Epidemic syphilis among homosexually active men in Sydney. Med J Aust 2005, 183: 179-183.
8. Cronin M, Domegan L, Thornton L, et al.: The epidemiology of infectious syphilis in the republic of Ireland. Euro Surveill 2004, 9: 14-17.
9. Buchacz K, Klausner JD, Kerndt PR, Brooks JT: HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr 2008, 47: 234-240.
10. Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 75: 3-17.
11. Hall HI, Song R, Janssen RS; HIV Incidence Surveillance Group: Estimation of HIV incidence in the United States. JAMA 2008, 300: 520-529.
12. Chesson HW, Dee TS, Aral SO: AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis 2003, 30: 419-424.
13. Rolfs RT, Joesoef MR, Hendershot EF, et al.; Syphilis and HIV Study Group: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337: 307-314.
14. Hutchinson CM, Hook EW, Shepherd M, et al.: Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994, 121: 94-99.
15. Rompalo AM, Lawlor J, Seaman P, et al.: Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 2001, 28: 448-454.
16. Romero-Jimenez MJ, Suarez Lozano I, Fajardo Pico JM, et al.: Malignant syphilis in patient with human immunodeficiency virus (HIV): Case report and literature review. Ann Med Interna (Madrid) 2003, 20: 45-48.
17. Haslett P, Laverty M: The prozone phenomenon in syphilis associated with HIV infection. Arch Intern Med 1994, 154: 1643-1644.
18. Hicks CB, Benson PM, Lupton GP, Tramont EC: Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med 1987, 107: 492-495.
19. Centers for Disease Control and Prevention: Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008, 57: 872-875.
20. Peeling RW, Hook EW III:TThe pathogenesis of syphilis: the great mimicker, revisited. J Pathol 2006, 208: 224-232.
21. Buchacz K, Patel P, Taylor M, et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIVinfected patients with new syphilis infections. AIDS 2004, 18: 2075-2079.
22. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T: Syphilis and human immunodeficiency virus (HIV)-1 coinfection: Influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis 2006, 33: 143-148.
23. Palacios R, Jimenez-Onate F, Aguilar M, et al.: Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr 2007, 44: 356-359.
24. Sadiq ST, McSorley J, Copas AJ, et al.: The effects of early syphilis on CD4 counts and HIV-1 viral loads in blood and semen. Sex Transm Infect 2005, 81: 380-385.
25. Manfredi R, Sabbatani S, Pocaterra D, et al.: Syphilis does not seem to involve virological and immunological course of concurrent HIV disease. AIDS 2006, 20: 305-306.
26. Lukehart SA, Hook EW III, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 1988, 109: 855-862.
27. Ducas J, Robson HG.: Cerebrospinal penicillin levels during therapy for latent syphilis. JAMA 1981, 246: 2583-2584.
28. Late syphilis of the nervous system. In Modern Clinical Syphilology Diagnosis, Treatment, Case Study. Edited by Stokes JH, Beerman H, Ingraham NR. Philadelphia: WB Saunders; 1944: 967-1067.
29. Flood JM, Weinstock HS, Guroy ME, et al.: Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 1998, 177: 931-940.
30. Musher DM, Hamill RJ, Baughn RE: Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990, 113: 872-881.
31. Lee MA, Aynalem G, Kerndt P, et al.: Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007, 56: 625-628.
32. ChaoRJR, Khurana RN, Fawzi AA, et al.: Syphilis: reemergence of an old adversary. Ophthalmology 2006, 113: 2074-2079.
33. Hart GA: Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986, 104: 368-376.
34. Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004, 63: 85-88.
35. Marra CM, Maxwell CL, Collier AC, et al.: Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infectious Diseases 2007, 7: 37. http://www.biomedcentral.com/ 1471-2334/7/37. Accessed August 2008.
36. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006, 55(RR-11): 22-30.
37. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis 2004, 189: 369-376.
38. Libois A, DeWWit S, Poll B, et al.: HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007, 34: 141-144.
39. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM: Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Inf 2007, 83: 97-101.
40. Malone JL, Wallace MR, Hendrick BB, et al.: Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995, 99: 55-63.
41. Kingston MA, Higgins SP: Audit of the management of early syphilis at North Manchester General Hospital. Int J STD AIDS 2004, 15: 352-354.
42. Riedner G, Rusizoka M, Todd J, et al.: Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005, 353: 1236-1244.
43. Kiddugavu MG, Kiwanuka N, Wawer MJ, et al.: Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 2005, 32: 1-6.
44. Lukehart SA, Godornes C, Molini BJ, et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004, 351: 154-158.
45. Klausner JD, Kohn RP, Kent CK: Azithromycin versus penicillin for early syphilis [letter]. N Engl J Med 2006, 354: 204.
46. Dowell ME, Ross PG, Musher DM, et al.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93: 481-488.
47. Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virusinfected individuals. Clin Infect Dis 2000, 30: 540-544.
48. Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15: 328-332.
49. Aberg JA, Gallant JE, Anderson J, et al.: Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005, 39: 609-629.